The Liberatory Maneuver for the Treatment of Benign Paroxysmal Positional Vertigo (BPPV)

NCT ID: NCT01008124

Last Updated: 2021-03-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2009-11-30

Study Completion Date

2010-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is being done because the investigators would like to know how effective the Liberatory maneuver is in treating benign paroxysmal positional vertigo (BPPV).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

BPPV is a problem with the inner ear that causes brief periods of vertigo triggered by changes in the position of the head such as rolling, looking up, or bending down. BPPV is presently thought to be caused by small pieces of debris or crystals becoming displaced within the inner ear. It can be treated by moving the patient through a series of positions called a maneuver. There are 2 different maneuvers currently used to treat BPPV by the clinician called the liberatory maneuver and the canalith repositioning procedure. We would like to determine how effective the liberatory maneuver is in the treatment of BPPV compared to a placebo maneuver.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vertigo Vestibular Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Liberatory Maneuver

Liberatory Maneuver

Group Type EXPERIMENTAL

Liberatory Maneuver

Intervention Type OTHER

3 cycles of the liberatory maneuver initial session.

Placebo Maneuver

Placebo Maneuver

Group Type PLACEBO_COMPARATOR

Placebo maneuver

Intervention Type OTHER

3 cycles placebo maneuver initial session.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Liberatory Maneuver

3 cycles of the liberatory maneuver initial session.

Intervention Type OTHER

Placebo maneuver

3 cycles placebo maneuver initial session.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Semont Maneuver

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* BPPV involving the posterior canal on only one side

Exclusion Criteria

* No other canals involved (anterior canal or lateral canal), no central nervous system disorder, and no other medical condition that would not enable the individual to have the maneuver done.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Northwestern University

OTHER

Sponsor Role collaborator

Midwestern University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Janet Odry Helminski, PhD

Dr

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Janet O. Helminski, PhD

Role: PRINCIPAL_INVESTIGATOR

Midwestern University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chicago Dizziness and Hearing

Chicago, Illinois, United States

Site Status

Midwestern University

Downers Grove, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Salvinelli F, Trivelli M, Casale M, Firrisi L, Di Peco V, D'Ascanio L, Greco F, Miele A, Petitti T, Bernabei R. Treatment of benign positional vertigo in the elderly: a randomized trial. Laryngoscope. 2004 May;114(5):827-31. doi: 10.1097/00005537-200405000-00007.

Reference Type BACKGROUND
PMID: 15126738 (View on PubMed)

Massoud EA, Ireland DJ. Post-treatment instructions in the nonsurgical management of benign paroxysmal positional vertigo. J Otolaryngol. 1996 Apr;25(2):121-5.

Reference Type BACKGROUND
PMID: 8683652 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MWU 1718

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Lithium in Multiple System Atrophy
NCT00997672 TERMINATED PHASE2
Stemchymal® for Polyglutamine Spinocerebellar Ataxia
NCT06397274 NOT_YET_RECRUITING PHASE2
Novel Therapies for Essential Tremor
NCT00018564 COMPLETED PHASE3